Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-06-12 17:33:21 UTC |
---|
Update Date | 2021-09-14 15:44:46 UTC |
---|
HMDB ID | HMDB0060546 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Norbuprenorphine |
---|
Description | Norbuprenorphine is the primary active metabolite of buprenorphine. Norbuprenorphine acts as a μ-opioid, δ-opioid, and nociceptin receptor full agonist, as well as a κ-opioid receptor partial agonist. Norbuprenorphine crosses the blood-brain-barrier similarly to buprenorphine and likely contributes to its effects. It was observed that Intravenous administration of norbuprenorphine at 1 to 3 mg/kg decreased respiratory rate, whereas buprenorphine had no effect up to 3 mg/kg in rats. (Wikipedia ) |
---|
Structure | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1)=C(O)C=C4 InChI=1S/C25H35NO4/c1-21(2,3)22(4,28)16-13-23-8-9-25(16,29-5)20-24(23)10-11-26-17(23)12-14-6-7-15(27)19(30-20)18(14)24/h6-7,16-17,20,26-28H,8-13H2,1-5H3/t16-,17-,20-,22+,23-,24+,25-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Des(cyclopropylmethyl)buprenorphine | HMDB | N-Desalkylbuprenorphine | HMDB |
|
---|
Chemical Formula | C25H35NO4 |
---|
Average Molecular Weight | 413.5497 |
---|
Monoisotopic Molecular Weight | 413.256608613 |
---|
IUPAC Name | (1S,2R,6S,14R,15R,16R)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-ol |
---|
Traditional Name | (1S,2R,6S,14R,15R,16R)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1)=C(O)C=C4 |
---|
InChI Identifier | InChI=1S/C25H35NO4/c1-21(2,3)22(4,28)16-13-23-8-9-25(16,29-5)20-24(23)10-11-26-17(23)12-14-6-7-15(27)19(30-20)18(14)24/h6-7,16-17,20,26-28H,8-13H2,1-5H3/t16-,17-,20-,22+,23-,24+,25-/m1/s1 |
---|
InChI Key | YOYLLRBMGQRFTN-IOMBULRVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenanthrenes and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenanthrenes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenanthrene
- Azaspirodecane
- Tetralin
- Coumaran
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Tertiary alcohol
- Dialkyl ether
- Secondary aliphatic amine
- Ether
- Secondary amine
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Amine
- Organooxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Alcohol
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Norbuprenorphine,1TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3068.2 | Semi standard non polar | 33892256 | Norbuprenorphine,1TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3120.3 | Semi standard non polar | 33892256 | Norbuprenorphine,1TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3076.9 | Semi standard non polar | 33892256 | Norbuprenorphine,2TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3094.8 | Semi standard non polar | 33892256 | Norbuprenorphine,2TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3056.0 | Semi standard non polar | 33892256 | Norbuprenorphine,2TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3093.2 | Semi standard non polar | 33892256 | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3131.5 | Semi standard non polar | 33892256 | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3386.3 | Standard non polar | 33892256 | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3281.2 | Standard polar | 33892256 | Norbuprenorphine,1TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3321.0 | Semi standard non polar | 33892256 | Norbuprenorphine,1TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3342.4 | Semi standard non polar | 33892256 | Norbuprenorphine,1TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3285.2 | Semi standard non polar | 33892256 | Norbuprenorphine,2TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3527.7 | Semi standard non polar | 33892256 | Norbuprenorphine,2TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3500.8 | Semi standard non polar | 33892256 | Norbuprenorphine,2TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3521.0 | Semi standard non polar | 33892256 | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3764.3 | Semi standard non polar | 33892256 | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 4023.3 | Standard non polar | 33892256 | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3540.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9135000000-45e0d329ab9294ed4317 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (2 TMS) - 70eV, Positive | splash10-05g3-9001010000-5c6c16b735846e565925 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS ("Norbuprenorphine,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-d0e136497c0156c9680f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-b04b0200f02b897bb6ef | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-18c86464a0d8a8e11bf8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0143900000-52c84cfc3c7de4f83891 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03dr-0490100000-61fc9d6ff83269e9fe09 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03ki-0691100000-b93b4447efa37aa300b0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0263900000-362c7ffa1fc4db260e07 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03ki-0691100000-cc22b459c3503e03c2de | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 30V, Positive-QTOF | splash10-03di-0000900000-a17b5bb24d801a8703c5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0000900000-7f319d742b7c88e6d294 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03dr-0490100000-61fc9d6ff83269e9fe09 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-e8bb505ed3edc3b3f233 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0000900000-b04b0200f02b897bb6ef | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-d0e136497c0156c9680f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 30V, Positive-QTOF | splash10-03di-0000900000-18c86464a0d8a8e11bf8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0143900000-52c84cfc3c7de4f83891 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-01ot-0009500000-f9107c3bc2684b887bb9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-01ot-1009200000-5c2addf9f89749701055 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-001i-4109000000-29b63bd2b3e8e8942b95 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Negative-QTOF | splash10-03di-0003900000-96dbf2e34e2566985c4e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Negative-QTOF | splash10-03di-2129500000-c9958eaf16725890f647 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Negative-QTOF | splash10-0002-1194000000-e835394a1e996708aa1c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-22add0760b63a0f18d04 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0001900000-bf64a5b4def2ecf8bf30 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0003900000-17c40c03c2942ffaf0ba | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|